The Absolute Oral Bioavailability and??Population-Based Pharmacokinetic Modelling of a Novel Dipepti...
The Absolute Oral Bioavailability and??Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers
About this item
Full title
Author / Creator
Publisher
Auckland: Adis international
Journal title
Language
English
Formats
Publication information
Publisher
Auckland: Adis international
Subjects
More information
Scope and Contents
Contents
Vildagliptin is a potent, selective, orally active inhibitor of dipeptidylpeptidase-IV being developed for the treatment of type 2 diabetes mellitus. The objective of this study was to assess the absolute oral bioavailability of vildagliptin by comparing the systemic exposure after oral and intravenous administration in healthy volunteers.
This...
Alternative Titles
Full title
The Absolute Oral Bioavailability and??Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68192568
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68192568
Other Identifiers
ISSN
0312-5963
E-ISSN
1179-1926
DOI
10.2165/00003088-200746090-00006
